Welch Allyn to Acquire Cardio Control

In a move that will expand its offerings in diagnostic cardiology, Welch Allyn, Inc. (Skaneateles Falls, NY, USA) has agreed to acquire Cardio Control NV (Amsterdam, The Netherlands) for around US$6.00 per share for all outstanding shares of Cardio Control's stock.

Cardio Control expects 2002 revenues to be about US$10 million. The company develops and sells diagnostic systems for heart and lung function and has introduced new software for recoding and analyzing combined medical and patient data for both centralized and remote use. The company's Medical Diagnostic Workstation offers 12-lead ECG, stress-test ECG, Holter ECG, mini-Holter ECG, spirometry, and ambulatory blood pressure. Cardio Control was an important contributor to the technology of the PC-based ECG and is a leading supplier in that market segment.

"This transaction furthers Welch Allyn's interest in advancing its worldwide cardio-pulmonary and information management market presence,” noted Bonnie Labosky, group vice president. "It also allows Welch Allyn to obtain core competencies and technologies to enhance the capture and management of patient clinical data in highly cost-effective ways.” Welch Allyn manufactures and sells diagnostic equipment, patient-monitoring systems, and miniature precision lamps.





Related Links:
Welch Allyn
Cardio Control